DNA testing and analytics technology company 23andMe and VG Acquisition Corp. (VGAC), a special purpose acquisition company (SPAC) sponsored by Richard Branson’s Virgin Group, announced

DNA testing and analytics technology company 23andMe and VG Acquisition Corp. (VGAC), a special purpose acquisition company (SPAC) sponsored by Richard Branson’s Virgin Group, announced
Eagle Genomics, a developer of AI-enabled data-driven microbiome discovery software platform, has closed $9 million in new scale-up funding. The consortium, led by Granpool Innovative
Sophia Genetics, a genomics data analysis company, closed a $110 million Series F financing round. The round was led by aMoon, a health-tech & life
DNAnexus, cloud-based genome informatics, and data management software platform, closed a $100 million in Series G funding round. Perceptive Advisors and Northpond Ventures co-led the